We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
AUM
$107M
AUM Growth
-$14.8M
Cap. Flow
-$4.72M
Cap. Flow %
-4.4%
Top 10 Hldgs %
34.96%
Holding
89
New
2
Increased
1
Reduced
71
Closed
3

Top Buys

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$2.97M
2
VTR icon
Ventas
VTR
+$65.2K

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$1.02M
2
CLX icon
Clorox
CLX
+$433K
3
BMY icon
Bristol-Myers Squibb
BMY
+$404K
4
MRK icon
Merck
MRK
+$354K
5
LLY icon
Eli Lilly
LLY
+$250K

Sector Composition

Rank Sector Weight
1 Consumer Staples 22.06%
2 Healthcare 13.84%
3 Technology 9.03%
4 Industrials 8.13%
5 Real Estate 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
1
Procter & Gamble
PG
$349B
$12.5M 11.67%
174,150
-2,620
-1% -$196K
CLX icon
2
Clorox
CLX
$11.6B
$3.95M 3.68%
34,207
-3,858
-10% -$433K
SH icon
3
ProShares Short S&P500
SH
$884M
$3.1M 2.89%
+17,242
New +$2.97M
MRK icon
4
Merck
MRK
$315B
$2.98M 2.78%
63,203
-6,656
-10% -$354K
CEF icon
5
Sprott Physical Gold and Silver Trust
CEF
$7.3B
$2.88M 2.68%
271,864
-9,000
-3% -$97.5K
INTC icon
6
Intel
INTC
$478B
$2.67M 2.49%
88,700
-3,900
-4% -$113K
CSX icon
7
CSX Corp
CSX
$94.3B
$2.33M 2.18%
260,400
-20,925
-7% -$205K
PHYS icon
8
Sprott Physical Gold
PHYS
$14.4B
$2.32M 2.16%
252,902
-4,500
-2% -$41.7K
BMY icon
9
Bristol-Myers Squibb
BMY
$124B
$2.29M 2.14%
38,725
-6,367
-14% -$404K
ABBV icon
10
AbbVie
ABBV
$450B
$2.21M 2.06%
40,710
-1,050
-3% -$68.3K
ESS icon
11
Essex Property Trust
ESS
$18.8B
$2.05M 1.91%
9,187
-966
-10% -$213K
T icon
12
AT&T
T
$152B
$2M 1.87%
81,470
-1,379
-2% -$35.2K
LLY icon
13
Eli Lilly
LLY
$1.05T
$1.95M 1.82%
23,350
-2,960
-11% -$250K
PSA icon
14
Public Storage
PSA
$55.8B
$1.94M 1.81%
9,174
-300
-3% -$61.1K
MCHP icon
15
Microchip Technology
MCHP
$44B
$1.91M 1.78%
88,700
-2,800
-3% -$60.4K
HE icon
16
Hawaiian Electric Industries
HE
$2.32B
$1.82M 1.7%
63,517
-4,200
-6% -$123K
MSFT icon
17
Microsoft
MSFT
$2.93T
$1.81M 1.68%
40,835
-4,000
-9% -$180K
CVX icon
18
Chevron
CVX
$373B
$1.78M 1.66%
22,609
-2,654
-11% -$223K
ABT icon
19
Abbott
ABT
$175B
$1.73M 1.61%
42,974
-500
-1% -$23.6K
CB
20
DELISTED
CHUBB CORPORATION
CB
$1.72M 1.6%
14,000
-2,000
-13% -$245K
KMB icon
21
Kimberly-Clark
KMB
$36B
$1.7M 1.59%
15,620
-1,150
-7% -$127K
GG
22
DELISTED
Goldcorp Inc
GG
$1.69M 1.57%
134,760
-4,480
-3% -$62.6K
PEP icon
23
PepsiCo
PEP
$187B
$1.63M 1.52%
17,273
-1,200
-6% -$114K
AXP icon
24
American Express
AXP
$242B
$1.53M 1.43%
20,700
-1,450
-7% -$112K
SO icon
25
Southern Company
SO
$107B
$1.48M 1.38%
33,150
-1,000
-3% -$43.9K

Similar funds

Bennicas & Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Bennicas & Associates held 89 positions worth $107M, down 12% from $122M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Bennicas & Associates withdrew a net $4.72M in Q3 2015, closing 3 positions and reducing 71 holdings. Its most notable exit was Star Bulk Carriers, an estimated $54K position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Bennicas & Associates opened a new position in ProShares Short S&P500 worth $3.1M.

  • Bennicas & Associates's largest Q3 2015 buy was ProShares Short S&P500: 17,242 shares worth $3.1M.
  • Bennicas & Associates added most to Ventas in Q3 2015, an estimated $65.2K increase.
  • Bennicas & Associates's biggest Q3 2015 reduction was Johnson & Johnson, cutting an estimated $1.02M.
  • Bennicas & Associates fully exited Star Bulk Carriers in Q3 2015, selling an estimated $54K.
  • Bennicas & Associates's ten largest holdings make up 35% of its $107M portfolio in Q3 2015.
  • Bennicas & Associates opened 2 new positions and closed 3 in Q3 2015.
  • Bennicas & Associates's portfolio value fell 12% quarter-over-quarter to $107M.

Based on Bennicas & Associates's 13F filing for Q3 2015, filed 28 Oct 2015.